Does NELFINAVIR Cause Hypertriglyceridaemia? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hypertriglyceridaemia have been filed in association with NELFINAVIR (VIRACEPT). This represents 2.7% of all adverse event reports for NELFINAVIR.
31
Reports of Hypertriglyceridaemia with NELFINAVIR
2.7%
of all NELFINAVIR reports
0
Deaths
23
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From NELFINAVIR?
Of the 31 reports, 23 (74.2%) required hospitalization, and 1 (3.2%) were considered life-threatening.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELFINAVIR. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does NELFINAVIR Cause?
Foetal exposure during pregnancy (290)
Drug resistance (117)
Lipodystrophy acquired (112)
Virologic failure (111)
Viral mutation identified (104)
Eyelid ptosis (88)
Pathogen resistance (87)
Mitochondrial toxicity (86)
Diplopia (83)
Progressive external ophthalmoplegia (73)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which NELFINAVIR Alternatives Have Lower Hypertriglyceridaemia Risk?
NELFINAVIR vs NELVUTAMIG
NELFINAVIR vs NEMOLIZUMAB
NELFINAVIR vs NEMOLIZUMAB-ILTO
NELFINAVIR vs NEOMYCIN
NELFINAVIR vs NEORAL